APOB and familial hypercholesterolemia: In addition other trials such as VA-HIT [39] and a trial conducted in hypercholesterolemia patients [40] showed that other treatments besides statins (gemfibrozil, a fibric acid derivative, and mipomersen, an apoB inhibitor) predominantly reduced the concentration of sdLDL particles.